Table 6.
Treatments1 | DAO (U/L) | D-LA (nmol/mL) |
---|---|---|
Control | 24.62 | 23.61a |
AGP | 23.08 | 13.64b |
XOS | 29.13 | 18.00a,b |
IAPS | 25.60 | 18.80a,b |
XOS + IAPS | 26.92 | 15.39b |
SEM | 1.10 | 1.12 |
P value | 0.49 | 0.04 |
Main effects | 2.74 | 2.39 |
XOS | ||
− | 26.39 | 21.21x |
+ | 28.03 | 16.69y |
IAPS | ||
− | 26.88 | 20.81 |
+ | 27.55 | 17.09 |
P values | ||
XOS | 0.57 | 0.08 |
IAPS | 0.81 | 0.15 |
XOS × IAPS | 0.32 | 0.66 |
a,bSuperscripts for means belong to 1-way ANOVA among 5 treatment groups.
x,ySuperscripts for means belong to 2 × 2 factorial arrangement (XOS and IAPS), excluding the AGP group.
Means with no common superscripts within the column of each classification are significantly different (P ≤ 0.05).
Abbreviations: DAO, diamine oxidase; D-LA, D-lactic acid.
Control, basal diet; AGP, basal diet supplemented with 50 mg/kg chlortetracycline; XOS, basal diet supplemented with 100 mg/kg XOS; IAPS, basal diet supplemented with 600 mg/kg IAPS; XOS + IAPS, basal diet supplemented with 100 mg/kg XOS and 600 mg/kg IAPS.